Efficacy and safety of MP1032 plus standard-of-care compared to standard-of-care in hospitalised patients with COVID-19: a multicentre, randomised double-blind, placebo-controlled phase 2a trial

https://www.thelancet.com/journals/lanepe/issue/vol37nonull/PIIS2666-7762(23)X0012-X